Status:
COMPLETED
The Bupivacaine Dose Sparing Effect of Intrathecal Epinephrine
Lead Sponsor:
Seoul Medical Center
Conditions:
Spinal Anesthesia
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
Intrathecal epinephrine has been known to increase the duration of spinal anesthesia, or increase the quality of anesthesia. However, there is still a controversy, and the mechanism of epinephrine is ...
Detailed Description
For patient undergoing total knee replacement arthroplasty, patients injected intrathecally with bupivacaine 8 mg were compared with those with bupivacaine 8 mg with 25 mcg of epinephrine, bupivacaine...
Eligibility Criteria
Inclusion
- patient undergoing total knee replacement arthroplasty
Exclusion
- patient with cardiac or pulmonary disease (ASA class III or more)
- patient undergone previous spine surgery
- patient undergoing revised knee replacement
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2011
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT01261078
Start Date
December 1 2010
End Date
July 1 2011
Last Update
July 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul Medical Center
Seoul, South Korea, 135-740